Improved Management of Patients With Recent-Onset Stable Chest Pain

Summary

In Germany, coronary CT offers an accurate and less burdensome alternative to cardiac catheterisation for evaluating suspected coronary artery disease, but it is still underused. The IMPRO stepped-wedge trial tests a new, nationwide care model (NVF) in 16 regions to improve guideline-based intersectoral implementation of coronary CT and assess its impact on cardiovascular outcomes and healthcare costs. If effective, the model of care (NVF) could be adopted across Germany to enhance care quality while reducing unnecessary procedures and expenses.

Eligibility

Inclusion Criteria:

* Age ≥30 years
* Suspected CAD with stable chest pain
* Ability to give informed consent

Exclusion Criteria:

* Known or previously treated (with PCI or CABG) obstructive CAD (defined as at least one coronary diameter stenosis ≥50%)
* Acute coronary syndrome
* Negative invasive coronary angiography or coronary CT within the last 5 years
* Already enrolled in the study
* Not covered by statutory health insurance
* Unable to give consent

Conditions2

Browse More Trials